NYSDA Publications

FDA Issues Preliminary Assessment that Certain Naloxone Products Have Potential to be Safe and Effective for OTC Use

The United States Food and Drug Administration (FDA) has issued a preliminary assessment that certain naloxone products can be safe and effective for over-the-counter (OTC) use.  FDA notes that naloxone is a medicine that can help reduce opioid overdose deaths and when administered timely, usually within minutes of the first signs of an opioid overdose, can counter the overdose effects.  To read the FDA announcement and summary of its preliminary assessment that certain naloxone products can be safely and effectively used OTC, use the link below.
https://www.fda.gov/news-events/press-announcements/fda-announces-preliminary-assessment-certain-naloxone-products-have-potential-be-safe-and-effective?utm_medium=email&utm_source=govdelivery
22380292641